Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

NCT02703623 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

196

Enrollment

OTHER

Sponsor class

Conditions

Castration Levels of Testosterone
Castration-Resistant Prostate Carcinoma
Metastatic Prostate Carcinoma
PSA Progression
Stage IV Prostate Adenocarcinoma AJCC v7

Interventions

DRUG: Abiraterone Acetate
DRUG: Apalutamide
DRUG: Cabazitaxel
DRUG: Carboplatin
BIOLOGICAL: Ipilimumab
OTHER: Laboratory Biomarker Analysis
DRUG: Prednisone

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]